Last 12 months
Inside the activity.
0 purchase rows · 63 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 29 |
| Jan 2026 | 0 | 10 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 04, 2017 Filed Apr 6, 2017 20:23 UTC |
Cil Jose E.Senior EVP, Pres. Burger King
|
GrantDividend Equivalent Rights · Derivative | 116.6162 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-026090 · doc4.xml · derivative · entry 13 Cil Jose E. · CIK 0001552282 · Senior EVP, Pres. Burger King 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 634.1258 Underlying: Common Shares · 116.6162 shares Expires not disclosed F6 · derivative.exercise_price: Each whole dividend equivalent right represents a contingent right to receive one common share. F7 · derivative.exercise_date: These dividend equivalent rights accrued on the 2016 restricted share unit award (the "2016 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 RSUs to which they relate. F7 · derivative.expiration_date: These dividend equivalent rights accrued on the 2016 restricted share unit award (the "2016 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 RSUs to which they relate. Read SEC document |
| April 04, 2017 Filed Apr 6, 2017 20:20 UTC |
Friesner JacquelineSee Remarks
|
GrantDividend Equivalent Rights · Derivative | 15.4811 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-026088 · doc4.xml · derivative · entry 16 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15.4811 Underlying: Common Shares · 15.4811 shares Expires not disclosed F6 · derivative.exercise_price: Each whole dividend equivalent right represents a contingent right to receive one common share. F9 · derivative.exercise_date: These dividend equivalent rights accrued on the 2017 restricted share unit award (the "2017 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2017 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2017 RSUs to which they relate. F9 · derivative.expiration_date: These dividend equivalent rights accrued on the 2017 restricted share unit award (the "2017 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2017 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2017 RSUs to which they relate. Read SEC document |
| April 04, 2017 Filed Apr 6, 2017 20:20 UTC |
Friesner JacquelineSee Remarks
|
GrantDividend Equivalent Rights · Derivative | 28.2379 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-026088 · doc4.xml · derivative · entry 13 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153.5496 Underlying: Common Shares · 28.2379 shares Expires not disclosed F6 · derivative.exercise_price: Each whole dividend equivalent right represents a contingent right to receive one common share. F7 · derivative.exercise_date: These dividend equivalent rights accrued on the 2016 restricted share unit award (the "2016 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 RSUs to which they relate. F7 · derivative.expiration_date: These dividend equivalent rights accrued on the 2016 restricted share unit award (the "2016 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 RSUs to which they relate. Read SEC document |
| April 04, 2017 Filed Apr 6, 2017 20:14 UTC |
Granat JillSee Remarks
|
GrantDividend Equivalent Rights · Derivative | 37.7384 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-026078 · doc4.xml · derivative · entry 16 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37.7384 Underlying: Common Shares · 37.7384 shares Expires not disclosed F6 · derivative.exercise_price: Each whole dividend equivalent right represents a contingent right to receive one common share. F9 · derivative.exercise_date: These dividend equivalent rights accrued on the 2017 restricted share unit award (the "2017 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2017 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2017 RSUs to which they relate. F9 · derivative.expiration_date: These dividend equivalent rights accrued on the 2017 restricted share unit award (the "2017 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2017 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2017 RSUs to which they relate. Read SEC document |
| April 04, 2017 Filed Apr 6, 2017 20:14 UTC |
Granat JillSee Remarks
|
GrantDividend Equivalent Rights · Derivative | 58.3081 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-026078 · doc4.xml · derivative · entry 13 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317.0629 Underlying: Common Shares · 58.3081 shares Expires not disclosed F6 · derivative.exercise_price: Each whole dividend equivalent right represents a contingent right to receive one common share. F7 · derivative.exercise_date: These dividend equivalent rights accrued on the 2016 restricted share unit award (the "2016 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 RSUs to which they relate. F7 · derivative.expiration_date: These dividend equivalent rights accrued on the 2016 restricted share unit award (the "2016 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 RSUs to which they relate. Read SEC document |
| April 04, 2017 Filed Apr 6, 2017 20:12 UTC |
Schwartz Daniel SDirector · Chief Executive Officer
|
GrantDividend Equivalent Rights · Derivative | 86.5974 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-026075 · doc4.xml · derivative · entry 16 Schwartz Daniel S · CIK 0001551400 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86.5974 Underlying: Common Shares · 86.5974 shares Expires not disclosed F6 · derivative.exercise_price: Each whole dividend equivalent right represents a contingent right to receive one common share. F9 · derivative.exercise_date: These dividend equivalent rights accrued on the 2017 restricted share unit award (the "2017 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2017 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2017 RSUs to which they relate. F9 · derivative.expiration_date: These dividend equivalent rights accrued on the 2017 restricted share unit award (the "2017 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2017 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2017 RSUs to which they relate. Read SEC document |
| April 04, 2017 Filed Apr 6, 2017 20:12 UTC |
Schwartz Daniel SDirector · Chief Executive Officer
|
GrantDividend Equivalent Rights · Derivative | 189.5014 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-026075 · doc4.xml · derivative · entry 13 Schwartz Daniel S · CIK 0001551400 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,030.4545 Underlying: Common Shares · 189.5014 shares Expires not disclosed F6 · derivative.exercise_price: Each whole dividend equivalent right represents a contingent right to receive one common share. F7 · derivative.exercise_date: These dividend equivalent rights accrued on the 2016 restricted share unit award (the "2016 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 RSUs to which they relate. F7 · derivative.expiration_date: These dividend equivalent rights accrued on the 2016 restricted share unit award (the "2016 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 RSUs to which they relate. Read SEC document |
| March 09, 2017 Filed Mar 10, 2017 18:07 UTC |
Van Damme AlexandreDirector
|
Exercise / conversionOption (right to buy) · Derivative | 141,105 | $0.00 Strike: $3.54 | $0.00 |
DisclosureSEC source: 0001209191-17-019783 · doc4.xml · derivative · entry 4 Van Damme Alexandre · CIK 0001552291 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 141,105 shares Expires 2022-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Due to an inadvertent error, the exercise price reported on the Form 4s previously filed was $3.98, instead of $3.54. F4 · derivative.exercise_date: These options are immediately exercisable. Read SEC document |
| March 09, 2017 Filed Mar 10, 2017 18:07 UTC |
Van Damme AlexandreDirector
|
PurchaseCommon Shares | 141,105 | $54.29 | $7,660,590.45 |
DisclosureSEC source: 0001209191-17-019783 · doc4.xml · nonDerivative · entry 3 Van Damme Alexandre · CIK 0001552291 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 5,419,230 F2 · kind: No profit was derived by the Reporting Person as a result of the sale and purchase transactions between the Reporting Person and Societe Familiale d'Investissements as reported herein. F3 · ownership.nature: Represents an indirect interest held by Societe Familiale d'Investissements. The Reporting Person is an indirect beneficial owner of equity interests in Societe Familiale d'Investissements. The Reporting Person disclaims beneficial ownership of any shares in which he does not have a pecuniary interest. Read SEC document |
| March 09, 2017 Filed Mar 10, 2017 18:07 UTC |
Van Damme AlexandreDirector
|
SaleCommon Shares | 141,105 | $54.29 | $7,660,590.45 |
DisclosureSEC source: 0001209191-17-019783 · doc4.xml · nonDerivative · entry 2 Van Damme Alexandre · CIK 0001552291 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,482 F2 · kind: No profit was derived by the Reporting Person as a result of the sale and purchase transactions between the Reporting Person and Societe Familiale d'Investissements as reported herein. Read SEC document |
| March 09, 2017 Filed Mar 10, 2017 18:07 UTC |
Van Damme AlexandreDirector
|
Exercise / conversionCommon Shares | 141,105 | $3.54 | $499,511.70 |
DisclosureSEC source: 0001209191-17-019783 · doc4.xml · nonDerivative · entry 1 Van Damme Alexandre · CIK 0001552291 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,587 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Due to an inadvertent error, the exercise price reported on the Form 4s previously filed was $3.98, instead of $3.54. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 23:28 UTC |
Schwartz Daniel SDirector · Chief Executive Officer
|
GrantRestricted Share Units · Derivative | 26,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015426 · doc4.xml · derivative · entry 15 Schwartz Daniel S · CIK 0001551400 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,850 Underlying: Common Shares · 26,850 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F10 · shares: The Issuer granted the 2017 restricted share units ("2017 RSUs") to the Reporting Person pursuant to the Issuer's 2016 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of his 2016 net bonus to purchase Investment Shares and received a matching grant of 2017 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $55.55 per share. The RSU Multiplier was 2.0 for executive vice presidents and above. If the Reporting Person sells 50% or less of the Investment Shares, he will forfeit 13,425 of the 2017 RSUs and a proportionate number of the remaining 2017 RSUs based on the number of Investment Shares sold. If the Reporting Person sells more than 50% of the Investment Shares, he will forfeit all of the 2017 RSUs. F11 · derivative.exercise_date: These restricted share units vest on December 31, 2021. F11 · derivative.expiration_date: These restricted share units vest on December 31, 2021. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 23:28 UTC |
Schwartz Daniel SDirector · Chief Executive Officer
|
GrantCommon Shares | 8,055 | $55.55 | $447,455.25 |
DisclosureSEC source: 0001209191-17-015426 · doc4.xml · nonDerivative · entry 1 Schwartz Daniel S · CIK 0001551400 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,852 F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2016 Bonus Swap Program under its Amended and Restated 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of his 2016 net bonus to purchase common shares at a purchase price of $55.55 per share ("Investment Shares"). F2 · price: Pursuant to the Issuer's 2014 Plan, the purchase price of the Investment Shares is, and the number of matching restricted share units described in footnote 10 below pursuant to the Issuer's 2016 Bonus Swap Program is calculated based on, the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 23, 2017. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 18:29 UTC |
Diaz-Sese EliasSee Remarks
|
GrantRestricted Share Units · Derivative | 17,060 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015428 · doc4.xml · derivative · entry 17 Diaz-Sese Elias · CIK 0001627676 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,060 Underlying: Common Shares · 17,060 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F10 · shares: The Issuer granted the 2017 restricted share units ("2017 RSUs") to the Reporting Person pursuant to the Issuer's 2016 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of his 2016 net bonus to purchase Investment Shares and received a matching grant of 2017 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $55.55 per share. The RSU Multiplier was 2.0 for executive vice presidents and above. If the Reporting Person sells 50% or less of the Investment Shares, he will forfeit 8,530 of the 2017 RSUs and a proportionate number of the remaining 2017 RSUs based on the number of Investment Shares sold. If the Reporting Person sells more than 50% of the Investment Shares, he will forfeit all of the 2017 RSUs. F11 · derivative.exercise_date: These restricted share units vest on December 31, 2021. F11 · derivative.expiration_date: These restricted share units vest on December 31, 2021. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 18:29 UTC |
Diaz-Sese EliasSee Remarks
|
GrantCommon Shares | 5,152 | $55.56 | $286,245.12 |
DisclosureSEC source: 0001209191-17-015428 · doc4.xml · nonDerivative · entry 1 Diaz-Sese Elias · CIK 0001627676 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,441 F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2016 Bonus Swap Program under its Amended and Restated 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of his 2016 net bonus to purchase common shares at a purchase price in Canadian dollars of $CAD72.86 per share ("Investment Shares"). The reported price represents the U.S. dollar equivalent following conversion using the closing exchange rate on February 23, 2017 of .7625. F1 · price: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2016 Bonus Swap Program under its Amended and Restated 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of his 2016 net bonus to purchase common shares at a purchase price in Canadian dollars of $CAD72.86 per share ("Investment Shares"). The reported price represents the U.S. dollar equivalent following conversion using the closing exchange rate on February 23, 2017 of .7625. F2 · price: Pursuant to the Issuer's 2014 Plan, (i) the purchase price of the Investment Shares is the last sales price of a common share of the Issuer on the Toronto Stock Exchange on the trading day immediately preceding the grant date, and (ii) the number of matching restricted share units described in footnote 10 below pursuant to the Issuer's 2016 Bonus Swap Program is calculated based on the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 23, 2017. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 23:34 UTC |
Cil Jose E.Senior EVP, Pres. Burger King
|
GrantRestricted Share Units · Derivative | 16,694 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015434 · doc4.xml · derivative · entry 15 Cil Jose E. · CIK 0001552282 · Senior EVP, Pres. Burger King 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,694 Underlying: Common Shares · 16,694 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F10 · shares: The Issuer granted the 2017 restricted share units ("2017 RSUs") to the Reporting Person pursuant to the Issuer's 2016 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of his 2016 net bonus to purchase Investment Shares and received a matching grant of 2017 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $55.55 per share. The RSU Multiplier was 2.0 for executive vice presidents and above. If the Reporting Person sells 50% or less of the Investment Shares, he will forfeit 8,347 of the 2017 RSUs and a proportionate number of the remaining 2017 RSUs based on the number of Investment Shares sold. If the Reporting Person sells more than 50% of the Investment Shares, he will forfeit all of the 2017 RSUs. F11 · derivative.exercise_date: These restricted share units vest on December 31, 2021. F11 · derivative.expiration_date: These restricted share units vest on December 31, 2021. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 23:34 UTC |
Cil Jose E.Senior EVP, Pres. Burger King
|
GrantCommon Shares | 5,008 | $55.55 | $278,194.40 |
DisclosureSEC source: 0001209191-17-015434 · doc4.xml · nonDerivative · entry 1 Cil Jose E. · CIK 0001552282 · Senior EVP, Pres. Burger King 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,095 F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2016 Bonus Swap Program under its Amended and Restated 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of his 2016 net bonus to purchase common shares at a purchase price of $55.55 per share ("Investment Shares"). F2 · price: Pursuant to the Issuer's 2014 Plan, the purchase price of the Investment Shares is, and the number of matching restricted share units described in footnote 10 below pursuant to the Issuer's 2016 Bonus Swap Program is calculated based on, the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 23, 2017. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 23:36 UTC |
Goncalves HeitorSee Remarks
|
GrantRestricted Share Units · Derivative | 14,192 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015436 · doc4.xml · derivative · entry 14 Goncalves Heitor · CIK 0001574954 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,192 Underlying: Common Shares · 14,192 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F10 · shares: The Issuer granted the 2017 restricted share units ("2017 RSUs") to the Reporting Person pursuant to the Issuer's 2016 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of his 2016 net bonus to purchase Investment Shares and received a matching grant of 2017 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $55.55 per share. The RSU Multiplier was 2.0 for executive vice presidents and above. If the Reporting Person sells 50% or less of the Investment Shares, he will forfeit 7,096 of the 2017 RSUs and a proportionate number of the remaining 2017 RSUs based on the number of Investment Shares sold. If the Reporting Person sells more than 50% of the Investment Shares, he will forfeit all of the 2017 RSUs. F11 · derivative.exercise_date: These restricted share units vest on December 31, 2021. F11 · derivative.expiration_date: These restricted share units vest on December 31, 2021. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 23:36 UTC |
Goncalves HeitorSee Remarks
|
GrantCommon Shares | 4,257 | $55.55 | $236,476.35 |
DisclosureSEC source: 0001209191-17-015436 · doc4.xml · nonDerivative · entry 1 Goncalves Heitor · CIK 0001574954 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,029 F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2016 Bonus Swap Program under its Amended and Restated 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of his 2016 net bonus to purchase common shares at a purchase price of $55.55 per share ("Investment Shares"). F2 · price: Pursuant to the Issuer's 2014 Plan, the purchase price of the Investment Shares is, and the number of matching restricted share units described in footnote 10 below pursuant to the Issuer's 2016 Bonus Swap Program is calculated based on, the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 23, 2017. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 23:35 UTC |
Kobza JoshuaCFO
|
GrantRestricted Share Units · Derivative | 20,114 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015435 · doc4.xml · derivative · entry 13 Kobza Joshua · CIK 0001574771 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,114 Underlying: Common Shares · 20,114 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F12 · shares: The Issuer granted the 2017 restricted share units ("2017 RSUs") to the Reporting Person pursuant to the Issuer's 2016 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of his 2016 net bonus to purchase Investment Shares and received a matching grant of 2017 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $55.55 per share. The RSU Multiplier was 2.0 for executive vice presidents and above. If the Reporting Person sells 50% or less of the Investment Shares, he will forfeit 10,057 of the 2017 RSUs and a proportionate number of the remaining 2017 RSUs based on the number of Investment Shares sold. If the Reporting Person sells more than 50% of the Investment Shares, he will forfeit all of the 2017 RSUs. F13 · derivative.exercise_date: These restricted share units vest on December 31, 2021. F13 · derivative.expiration_date: These restricted share units vest on December 31, 2021. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 23:35 UTC |
Kobza JoshuaCFO
|
GrantCommon Shares | 6,034 | $55.55 | $335,188.70 |
DisclosureSEC source: 0001209191-17-015435 · doc4.xml · nonDerivative · entry 1 Kobza Joshua · CIK 0001574771 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,377 F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2016 Bonus Swap Program under its Amended and Restated 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of his 2016 net bonus to purchase common shares at a purchase price of $55.55 per share ("Investment Shares"). F2 · price: Pursuant to the Issuer's 2014 Plan, the purchase price of the Investment Shares is, and the number of matching restricted share units described in footnote 12 below pursuant to the Issuer's 2016 Bonus Swap Program is calculated based on, the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 23, 2017. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 23:30 UTC |
Friesner JacquelineSee Remarks
|
GrantOption (right to buy) · Derivative | 20,000 | $0.00 Strike: $55.55 | $0.00 |
DisclosureSEC source: 0001209191-17-015430 · doc4.xml · derivative · entry 16 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Shares · 20,000 shares Expires 2027-02-23 Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 23:30 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 4,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015430 · doc4.xml · derivative · entry 15 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,800 Underlying: Common Shares · 4,800 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F10 · shares: The Issuer granted the 2017 restricted share units ("2017 RSUs") to the Reporting Person pursuant to the Issuer's 2016 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of her 2016 net bonus to purchase Investment Shares and received a matching grant of 2017 RSUs in an amount equal to 50% of her gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $55.55 per share. The RSU Multiplier was 1.75 for vice presidents. If the Reporting Person sells 50% or less of the Investment Shares, she will forfeit 2,400 of the 2017 RSUs and a proportionate number of the remaining 2017 RSUs based on the number of Investment Shares sold. If the Reporting Person sells more than 50% of the Investment Shares, she will forfeit all of the 2017 RSUs. F11 · derivative.exercise_date: These restricted share units vest on December 31, 2021. F11 · derivative.expiration_date: These restricted share units vest on December 31, 2021. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 23:30 UTC |
Friesner JacquelineSee Remarks
|
GrantCommon Shares | 1,645 | $55.55 | $91,379.75 |
DisclosureSEC source: 0001209191-17-015430 · doc4.xml · nonDerivative · entry 1 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,405 F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of her investment rights pursuant to the Issuer's 2016 Bonus Swap Program under its Amended and Restated 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of her 2016 net bonus to purchase common shares at a purchase price of $55.55 per share ("Investment Shares"). F2 · price: Pursuant to the Issuer's 2014 Plan, the purchase price of the Investment Shares is, and the number of matching restricted share units described in footnote 10 below pursuant to the Issuer's 2016 Bonus Swap Program is calculated based on, the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 23, 2017. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 23:33 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 11,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015433 · doc4.xml · derivative · entry 15 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,701 Underlying: Common Shares · 11,701 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F10 · shares: The Issuer granted the 2017 restricted share units ("2017 RSUs") to the Reporting Person pursuant to the Issuer's 2016 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of her 2016 net bonus to purchase Investment Shares and received a matching grant of 2017 RSUs in an amount equal to 50% of her gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $55.55 per share. The RSU Multiplier was 2.0 for executive vice presidents and above. If the Reporting Person sells 50% or less of the Investment Shares, she will forfeit 5,850 of the 2017 RSUs and a proportionate number of the remaining 2017 RSUs based on the number of Investment Shares sold. If the Reporting Person sells more than 50% of the Investment Shares, she will forfeit all of the 2017 RSUs. F11 · derivative.exercise_date: These restricted share units vest on December 31, 2021. F11 · derivative.expiration_date: These restricted share units vest on December 31, 2021. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 23:33 UTC |
Granat JillSee Remarks
|
GrantCommon Shares | 3,510 | $55.55 | $194,980.50 |
DisclosureSEC source: 0001209191-17-015433 · doc4.xml · nonDerivative · entry 1 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,589 F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of her investment rights pursuant to the Issuer's 2016 Bonus Swap Program under its Amended and Restated 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of her 2016 net bonus to purchase common shares at a purchase price of $55.55 per share ("Investment Shares"). F2 · price: Pursuant to the Issuer's 2014 Plan, the purchase price of the Investment Shares is, and the number of matching restricted share units described in footnote 10 below pursuant to the Issuer's 2016 Bonus Swap Program is calculated based on, the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 23, 2017. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 17:38 UTC |
Diaz-Sese EliasSee Remarks
|
GrantDividend Equivalent Rights · Derivative | 162.8889 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002726 · doc4.xml · derivative · entry 15 Diaz-Sese Elias · CIK 0001627676 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 646.887 Underlying: Common Shares · 162.8889 shares Expires not disclosed F6 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive one common share. F7 · derivative.exercise_date: These dividend equivalent rights accrued on the 2016 restricted share unit award (the "2016 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 RSUs to which they relate. F7 · derivative.expiration_date: These dividend equivalent rights accrued on the 2016 restricted share unit award (the "2016 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 RSUs to which they relate. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 22:52 UTC |
Schwartz Daniel SDirector · Chief Executive Officer
|
GrantDividend Equivalent Rights · Derivative | 211.7556 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002752 · doc4.xml · derivative · entry 13 Schwartz Daniel S · CIK 0001551400 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 840.9531 Underlying: Common Shares · 211.7556 shares Expires not disclosed F6 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive one common share. F7 · derivative.exercise_date: These dividend equivalent rights accrued on the 2016 restricted share unit award (the "2016 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 RSUs to which they relate. F7 · derivative.expiration_date: These dividend equivalent rights accrued on the 2016 restricted share unit award (the "2016 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 RSUs to which they relate. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 22:48 UTC |
Kobza JoshuaCFO
|
GrantDividend Equivalent Rights · Derivative | 1,279.711 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002748 · doc4.xml · derivative · entry 12 Kobza Joshua · CIK 0001574771 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,082.1653 Underlying: Common Shares · 1,279.711 shares Expires not disclosed F8 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive one common share, subject to increase or decrease based on the results of the Issuer performance condition. F9 · derivative.exercise_date: These dividend equivalent rights accrued on the 2016 PBRSUs. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 PBRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 PBRSUs to which they relate. F9 · derivative.expiration_date: These dividend equivalent rights accrued on the 2016 PBRSUs. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 PBRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 PBRSUs to which they relate. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 22:48 UTC |
Kobza JoshuaCFO
|
GrantDividend Equivalent Rights · Derivative | 97.7334 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002748 · doc4.xml · derivative · entry 10 Kobza Joshua · CIK 0001574771 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 388.1323 Underlying: Common Shares · 97.7334 shares Expires not disclosed F5 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive one common share. F6 · derivative.exercise_date: These dividend equivalent rights accrued on the 2016 restricted share unit award (the "2016 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 RSUs to which they relate. F6 · derivative.expiration_date: These dividend equivalent rights accrued on the 2016 restricted share unit award (the "2016 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 RSUs to which they relate. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 22:41 UTC |
Friesner JacquelineSee Remarks
|
GrantDividend Equivalent Rights · Derivative | 31.554 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002732 · doc4.xml · derivative · entry 13 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125.3117 Underlying: Common Shares · 31.554 shares Expires not disclosed F6 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive one common share. F7 · derivative.exercise_date: These dividend equivalent rights accrued on the 2016 restricted share unit award (the "2016 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 RSUs to which they relate. F7 · derivative.expiration_date: These dividend equivalent rights accrued on the 2016 restricted share unit award (the "2016 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 RSUs to which they relate. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 22:44 UTC |
Granat JillSee Remarks
|
GrantDividend Equivalent Rights · Derivative | 65.1556 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002738 · doc4.xml · derivative · entry 13 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258.7548 Underlying: Common Shares · 65.1556 shares Expires not disclosed F6 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive one common share. F7 · derivative.exercise_date: These dividend equivalent rights accrued on the 2016 restricted share unit award (the "2016 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 RSUs to which they relate. F7 · derivative.expiration_date: These dividend equivalent rights accrued on the 2016 restricted share unit award (the "2016 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 RSUs to which they relate. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 22:35 UTC |
Goncalves HeitorSee Remarks
|
GrantDividend Equivalent Rights · Derivative | 108.5926 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002720 · doc4.xml · derivative · entry 12 Goncalves Heitor · CIK 0001574954 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 431.258 Underlying: Common Shares · 108.5926 shares Expires not disclosed F6 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive one common share. F7 · derivative.exercise_date: These dividend equivalent rights accrued on the 2016 restricted share unit award (the "2016 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 RSUs to which they relate. F7 · derivative.expiration_date: These dividend equivalent rights accrued on the 2016 restricted share unit award (the "2016 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 RSUs to which they relate. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 22:31 UTC |
Cil Jose E.Senior EVP, Pres. Burger King
|
GrantDividend Equivalent Rights · Derivative | 130.3111 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002711 · doc4.xml · derivative · entry 13 Cil Jose E. · CIK 0001552282 · Senior EVP, Pres. Burger King 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 517.5096 Underlying: Common Shares · 130.3111 shares Expires not disclosed F6 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive one common share. F7 · derivative.exercise_date: These dividend equivalent rights accrued on the 2016 restricted share unit award (the "2016 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 RSUs to which they relate. F7 · derivative.expiration_date: These dividend equivalent rights accrued on the 2016 restricted share unit award (the "2016 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 RSUs to which they relate. Read SEC document |
| December 30, 2016 Filed Jan 3, 2017 15:11 UTC |
FRANKLIN MARTIN EDirector
|
GrantCommon Shares | 2,504 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-000120 · doc4.xml · nonDerivative · entry 1 FRANKLIN MARTIN E · CIK 0000940603 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,099 F1 · shares: Represents restricted stock units that are earned and vested upon grant and that settle upon termination of board service. Read SEC document |
| December 30, 2016 Filed Jan 3, 2017 20:33 UTC |
FRIBOURG PAUL JDirector
|
GrantCommon Shares | 2,921 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-000134 · doc4.xml · nonDerivative · entry 1 FRIBOURG PAUL J · CIK 0001070938 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,848 F1 · shares: Represents restricted stock units that are earned and vested upon grant and that settle upon termination of board service. Read SEC document |
| December 30, 2016 Filed Jan 3, 2017 21:25 UTC |
Van Damme AlexandreDirector
|
GrantCommon Shares | 2,504 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-000233 · doc4.xml · nonDerivative · entry 1 Van Damme Alexandre · CIK 0001552291 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,482 F1 · shares: Represents restricted stock units that are earned and vested upon grant and that settle upon termination of board service. Read SEC document |
| December 30, 2016 Filed Jan 3, 2017 20:54 UTC |
Thomas V MilroyDirector
|
GrantCommon Shares | 2,504 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-000158 · doc4.xml · nonDerivative · entry 1 Thomas V Milroy · CIK 0001627664 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,735 F1 · shares: Represents restricted stock units that are earned and vested upon grant and that settle upon termination of board service. Read SEC document |
| December 30, 2016 Filed Jan 3, 2017 14:50 UTC |
Caira MarcDirector
|
GrantCommon Shares | 3,130 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-000092 · doc4.xml · nonDerivative · entry 1 Caira Marc · CIK 0001627707 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,643 F1 · shares: Represents restricted stock units that are earned and vested upon grant and that settle upon termination of board service. Read SEC document |
| December 30, 2016 Filed Jan 3, 2017 21:22 UTC |
Thompson Motta Roberto MosesDirector
|
GrantCommon Shares | 2,086 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-000217 · doc4.xml · nonDerivative · entry 1 Thompson Motta Roberto Moses · CIK 0001575768 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,526 F1 · shares: Represents restricted stock units that are earned and vested upon grant and that settle upon termination of board service. Read SEC document |
| December 30, 2016 Filed Jan 3, 2017 21:12 UTC |
Sicupira CeciliaDirector
|
GrantCommon Shares | 966 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-000187 · doc4.xml · nonDerivative · entry 1 Sicupira Cecilia · CIK 0001680286 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 966 F1 · shares: Represents restricted stock units that are earned and vested upon grant and that settle upon termination of board service. Read SEC document |
| December 30, 2016 Filed Jan 3, 2017 21:01 UTC |
Sicupira Carlos AlbertoDirector
|
GrantCommon Shares | 2,921 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-000167 · doc4.xml · nonDerivative · entry 1 Sicupira Carlos Alberto · CIK 0001552490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,386 F1 · shares: Represents restricted stock units that are earned and vested upon grant and that settle upon termination of board service. Read SEC document |
| December 30, 2016 Filed Jan 3, 2017 20:51 UTC |
Hedayat AliDirector
|
GrantCommon Shares | 966 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-000151 · doc4.xml · nonDerivative · entry 1 Hedayat Ali · CIK 0001679916 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,966 F1 · shares: Represents restricted stock units that are earned and vested upon grant and that settle upon termination of board service. Read SEC document |
| December 30, 2016 Filed Jan 3, 2017 20:43 UTC |
Golden NeilDirector
|
GrantCommon Shares | 2,915 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-000139 · doc4.xml · nonDerivative · entry 1 Golden Neil · CIK 0001677020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,915 F1 · shares: Represents restricted stock units that are earned and vested upon grant and that settle upon termination of board service. Read SEC document |
| December 30, 2016 Filed Jan 3, 2017 19:41 UTC |
Behring AlexandreDirector
|
GrantCommon Shares | 5,008 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-000089 · doc4.xml · nonDerivative · entry 1 Behring Alexandre · CIK 0001421706 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,862 F1 · shares: Represents restricted stock units that are earned and vested upon grant and that settle upon termination of board service. Read SEC document |
| October 04, 2016 Filed Oct 12, 2016 00:06 UTC |
Cil Jose E.Senior EVP, Pres. Burger King
|
GrantDividend Equivalent Rights · Derivative | 130.3562 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-145646 · doc4.xml · derivative · entry 13 Cil Jose E. · CIK 0001552282 · Senior EVP, Pres. Burger King 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 387.1985 Underlying: Common Shares · 130.3562 shares Expires not disclosed F6 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive one common share. F7 · derivative.exercise_date: These dividend equivalent rights accrued on the 2016 restricted share unit award (the "2016 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 RSUs to which they relate. F7 · derivative.expiration_date: These dividend equivalent rights accrued on the 2016 restricted share unit award (the "2016 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 RSUs to which they relate. Read SEC document |
| October 04, 2016 Filed Oct 12, 2016 00:04 UTC |
Kobza JoshuaCFO
|
GrantDividend Equivalent Rights · Derivative | 1,280.1536 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-145644 · doc4.xml · derivative · entry 12 Kobza Joshua · CIK 0001574771 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,802.4543 Underlying: Common Shares · 1,280.1536 shares Expires not disclosed F8 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive one common share, subject to increase or decrease based on the results of the Issuer performance condition. F9 · derivative.exercise_date: These dividend equivalent rights accrued on the 2016 PBRSUs. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 PBRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 PBRSUs to which they relate. F9 · derivative.expiration_date: These dividend equivalent rights accrued on the 2016 PBRSUs. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 PBRSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 PBRSUs to which they relate. Read SEC document |
| October 04, 2016 Filed Oct 12, 2016 00:04 UTC |
Kobza JoshuaCFO
|
GrantDividend Equivalent Rights · Derivative | 97.7672 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-145644 · doc4.xml · derivative · entry 10 Kobza Joshua · CIK 0001574771 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 290.3989 Underlying: Common Shares · 97.7672 shares Expires not disclosed F5 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive one common share. F6 · derivative.exercise_date: These dividend equivalent rights accrued on the 2016 restricted share unit award (the "2016 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 RSUs to which they relate. F6 · derivative.expiration_date: These dividend equivalent rights accrued on the 2016 restricted share unit award (the "2016 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 RSUs to which they relate. Read SEC document |
| October 04, 2016 Filed Oct 11, 2016 20:09 UTC |
Diaz-Sese EliasSee Remarks
|
GrantDividend Equivalent Rights · Derivative | 162.9453 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-145649 · doc4.xml · derivative · entry 15 Diaz-Sese Elias · CIK 0001627676 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 483.9981 Underlying: Common Shares · 162.9453 shares Expires not disclosed F6 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive one common share. F7 · derivative.exercise_date: These dividend equivalent rights accrued on the 2016 restricted share unit award (the "2016 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 RSUs to which they relate. F7 · derivative.expiration_date: These dividend equivalent rights accrued on the 2016 restricted share unit award (the "2016 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 RSUs to which they relate. Read SEC document |
| October 04, 2016 Filed Oct 12, 2016 00:20 UTC |
Friesner JacquelineSee Remarks
|
GrantDividend Equivalent Rights · Derivative | 31.5649 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-145656 · doc4.xml · derivative · entry 13 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93.7577 Underlying: Common Shares · 31.5649 shares Expires not disclosed F6 · derivative.exercise_price: Each dividend equivalent right represents a contingent right to receive one common share. F7 · derivative.exercise_date: These dividend equivalent rights accrued on the 2016 restricted share unit award (the "2016 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 RSUs to which they relate. F7 · derivative.expiration_date: These dividend equivalent rights accrued on the 2016 restricted share unit award (the "2016 RSUs"). Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the 2016 RSUs and vest proportionately with and are subject to settlement and expiration upon the same terms as the 2016 RSUs to which they relate. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.